Evotec - Research never stops

Assay Development & Screening Overview

Evotec is able to offer screening services for biochemical, functional and/or cellular responses using its proprietary high throughput screening (HTS) technology (FCS+plus) and/or other commercial platforms. This can be through providing access to its own 250,000 compound screening library or using the client's library of compounds.

Evotec’s offering:

  • Biochemical, functional and cellular screening
  • High content screening and high content analysis
  • Label-free screening (NMR, SPR, LC-MS)
  • Fragment based screening
  • Compound profiling
  • In vitro ADMET assays

Benefits to the partner:

  • Superior detection technology and increased assay sensitivity resulting in higher quality data and less false positives and false negatives
  • Assay miniaturization resulting in the use of less protein giving lower costs and faster lead-times to initiating screens  
  • Multiple readout parameters further enabling the reduction in false positives and negatives and providing high quality assay statistics resulting in the ability to screen highly challenging targets  
  • Strong track record in developing assays for HTS for numerous target classes (Ion Channels, GPCRs, Kinases, Nuclear Hormone Receptors, Proteases & Other Enzymes, Protein-Protein Interactions)

For more information, please contact us at info@evotec.com

Assay Development & Screening

High Throughput Screening

- read more

Fragment-based Drug Discovery: EVOlution

- read more

High Content Screening

- read more

Label Free Screening

- read more

Secondary Screening & Profiling

- read more

Electrophysiology

- read more

Screening Library

- read more

Assay Development

- read more